Trials / Conditions / Hypopharyngeal Squamous Cell Carcinoma

Hypopharyngeal Squamous Cell Carcinoma

13 registered clinical trials studyying Hypopharyngeal Squamous Cell Carcinoma — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN281 NCT06980038	National Cancer Institute (NCI)	Phase 2
Recruiting	Window of Opportunity in Preserving Laryngeal Function Trial NCT07423078	Matthew Spector	Phase 2
Not Yet Recruiting	Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer NCT07058805	Olgun Elicin	Phase 2
Recruiting	Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin a NCT06662058	Emory University	N/A
Recruiting	Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy f NCT06532279	NRG Oncology	Phase 2
Recruiting	Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluati NCT06914999	Emory University	EARLY_Phase 1
Recruiting	European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] NCT06137378	University of Leipzig	Phase 2
Withdrawn	Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carbopl NCT06084845	ECOG-ACRIN Cancer Research Group	Phase 2
Unknown	Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer NCT04296747	Peking Union Medical College Hospital	Phase 2
Completed	Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck NCT03258554	National Cancer Institute (NCI)	Phase 2 / Phase 3
Active Not Recruiting	Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma NCT02984410	European Organisation for Research and Treatment of Cancer - EORTC	N/A
Recruiting	Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of NCT02734537	ECOG-ACRIN Cancer Research Group	Phase 2
Terminated	Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck NCT02582008	Wake Forest University Health Sciences	EARLY_Phase 1